Role of ERCC1 expression in colorectal adenoma-carcinoma sequence and relation to other mismatch repair proteins expression, clinicopathological features and prognosis in mucinous and non-mucinous colorectal carcinoma
Author(s) -
AbdAlRahman Mohammad Foda,
Andrea Palicelli,
Abdelhadi M. Shebl,
Renzo Boldorini,
Khaled Elnaghi,
AmiraK El-Hawary
Publication year - 2019
Publication title -
indian journal of pathology and microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.217
H-Index - 31
eISSN - 0974-5130
pISSN - 0377-4929
DOI - 10.4103/ijpm.ijpm_684_18
Subject(s) - mucinous carcinoma , colorectal adenoma , ercc1 , colorectal cancer , adenoma , medicine , carcinoma , oncology , cancer research , adenocarcinoma , biology , cancer , gene , dna repair , biochemistry , nucleotide excision repair
There are several DNA repair pathways that protect cellular DNA from injury, such as nucleotide excision repair (NER) and mismatch repair (MMR). The protein product of the excision repair cross-complementation group 1 (ERCC1) gene plays a pivotal role in NER. The exact relationship between MMR proteins and ERCC1 is not well known in colorectal carcinoma (CRC).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom